TRPS1 and acquired factor X deficiency: Almost all cases of AFX/PDS (95.2%; 20/21) demonstrated TRPS1 immunoreactivity, with their expression predominantly at least moderate in intensity (90%; 18/20), yielding a median H-score of 240 (Figure 2 and Table 1).